A Multinational Comparison of Anti-Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific. [electronic resource]
- Ophthalmology. Retina 01 2019
- 16-26 p. digital
Publication Type: Journal Article; Review
2468-6530
10.1016/j.oret.2018.08.002 doi
Angiogenesis Inhibitors--administration & dosage Asia, Western Cost-Benefit Analysis Drug Costs--statistics & numerical data Humans Intravitreal Injections Public Health--economics Ranibizumab--administration & dosage Receptors, Vascular Endothelial Growth Factor--administration & dosage Recombinant Fusion Proteins--administration & dosage Retinal Diseases--drug therapy United Kingdom United States Vascular Endothelial Growth Factors--antagonists & inhibitors